Friday 6 November 2026 Export TVTX’s income statement to Excel — free account

Travere Therapeutics, Inc.

Travere Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $490.7 million, up 110.5% from fiscal 2024.

Revenue: +36.2%
EPS: −290.7%
Free cash flow: +6,379.8%
Total debt: +93.8%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

49.45 0.58 +1.19%

Follow TVTX

Alert me

Market cap: $4.7B
P/E: 0.0×
Fwd P/E: −145×
Dividend yield: —
F-score: 6/9
Altman Z: 1.78
Beneish M: −1.74
Dividend safety: n/a

Overview

Travere Therapeutics, Inc. (TVTX) P/E ratio

Alert me on P/E ratio

Travere Therapeutics, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 8.8× (December 2015) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/TVTX/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Travere Therapeutics, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/TVTX/metrics/pe-ratio">Travere Therapeutics, Inc. (TVTX) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Sep 2026	0.0×	—
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
43 more quarters	Free account

Against its own ten years

Low 0.0× High 8.8×

Ten-year median 0.0×

Current reading's percentile 92

Company	P/E ratio
LEGN Legend Biotech Corporation Sponsored ADR compare	n/m
DFTX Definium Therapeutics, Inc. compare	n/m
ERAS Erasca, Inc. compare	n/m
TVTX Travere Therapeutics, Inc.	n/m
DNTH Dianthus Therapeutics, Inc. compare	n/m
MANE Veradermics Incorporated compare	n/m
CRSP CRISPR Therapeutics AG compare	n/m
COGT Cogent Biosciences, Inc. compare	n/m
EWTX Edgewise Therapeutics, Inc. compare	4.9×
Biotechnology industry median	10.6×
Healthcare sector median	24.5×
Market median	17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Travere Therapeutics, Inc. (TVTX) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on TVTX

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on TVTX

Stockrow Weekly